By Patricia Weiss BERLIN, Jan 13 (Reuters) - The pharmaceuticals and agriculture group Bayer aims to return its pharmaceuticals business to mid-single-digit percentage growth by no later than 2027 and ...

This story is part of Forbes’ coverage of India’s Richest 2025. See the full list here. Brothers Sudhir and Samir Mehta are riding the momentum of India’s ambition to become the world’s pharmacy. In ...

On a day when AbbVie revealed booming sales of Skyrizi and Rinvoq and another positive adjustment to its 2025 guidance, the company also is reportedly angling to bolster its long-term prospects by way ...

Jan 28 (Reuters) - India's Gland Pharma reported a nearly 28% jump in third-quarter profit on Wednesday, boosted by strong sales in the key European and U.S. markets. The Hyderabad-based company ...

Using half-baked knowledge in the pharmaceutical world is like trying to launch a rocket without the fuel- It’s bound to fail. The Pharmaceutical industry of India is a Key growth accelerator, and has ...

In his first public appearance as Incyte’s CEO, Bill Meury outlined his priorities for the company, which include taking a “fresh look” at the business’ R&D, operating expenses and capital allocation.

U.S. and Canada transaction supports continued access to RADICAVA® for people living with ALS while enabling Tanabe Pharma America to focus on future growth and innovation JERSEY CITY, N.J., Dec. 22, ...

For my initial rating of Amneal Pharmaceuticals, I am calling it a buy. I was impressed by its large, diversified portfolio of therapies across clinical segments, and active pipeline of future ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

The pharmaceutical business model relies on clinically testing many compounds to approve a single blockbuster that recoups all investments. The challenge in drug development is that clinical efficacy ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today announces participation and ...

Helus Pharma builds on the strong foundation originally created as Cybin Inc., reflecting the Company’s ongoing transformation to a commercial stage pharmaceutical company Helus Pharma commences ...